• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Gynecologic Oncology

Gynecologic Oncology

  • Contact Us
  • 888-GYNONC1

GYN 101 EP0057-201

Advanced Ovarian Cancer: Platinum resistant, Advanced Ovarian Cancer: Platinum sensitive

A Phase 2 study to evaluate the safety and efficacy of EP0057 in combination with olaparib in advanced ovarian cancer patients.

Cancer Types: GYN, Ovarian

Lines of Therapy: 2nd Line Metastatic, 3rd Line+ Metastatic

View Details on ClinicalTrials.gov

Back to Clinical Trials

Footer

 

To schedule an appointment:

888-GYNONC1

 

Copyright © 2025 Gynecologic Oncology